NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
-1.83%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.21B
AUM Growth
-$221M
(-15%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
42.91%
Holding
147
New
18
Increased
38
Reduced
57
Closed
11
Top Buys
| 1 |
RH
RH
|
+$11.8M |
| 2 |
Hilton Grand Vacations
HGV
|
+$9.57M |
| 3 |
Gogo Inc
GOGO
|
+$8.54M |
| 4 |
THRD
Third Harmonic Bio
THRD
|
+$8.46M |
| 5 |
Avalo Therapeutics
AVTX
|
+$7.21M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$155M |
| 2 |
Peloton Interactive
PTON
|
+$18.1M |
| 3 |
BlackSky Technology
BKSY
|
+$14.9M |
| 4 |
Pathward Financial
CASH
|
+$14.1M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$13.7M |
Sector Composition
| 1 | Healthcare | 63.52% |
| 2 | Consumer Discretionary | 15.44% |
| 3 | Communication Services | 7.06% |
| 4 | Financials | 4.59% |
| 5 | Industrials | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UPB
76
Upstream Bio, Inc. Common Stock
UPB
$966M
| $3.64M | 0.14% |
594,971
-5,029
| -0.8% | -$30.8K |
|
77
Dyne Therapeutics
DYN
$1.89B
| $3.61M | 0.14% |
+345,062
| New | +$3.61M |
|
78
Astria Therapeutics
ATXS
$442M
| $3.58M | 0.14% |
669,530
-5,470
| -0.8% | -$29.2K |
|
79
Gaia
GAIA
$146M
| $3.52M | 0.14% |
914,618
-411
| -0% | -$1.58K |
|
|
THTX
80
Theratechnologies
THTX
$150M
| $3.48M | 0.14% |
2,422,563
-259,665
| -10% | -$373K |
|
81
Columbus McKinnon
CMCO
$417M
| $3.39M | 0.13% |
+200,000
| New | +$3.39M |
|
82
DHI Group
DHX
$143M
| $3.3M | 0.13% |
2,374,027
-2,579
| -0.1% | -$3.59K |
|
83
NN Inc
NNBR
$121M
| $3.26M | 0.13% |
1,441,416
-17,000
| -1% | -$38.4K |
|
84
EyePoint Pharmaceuticals
EYPT
$919M
| $3.21M | 0.13% |
593,091
-6,909
| -1% | -$37.4K |
|
|
IRD
85
Opus Genetics, Inc. Common Stock
IRD
$84.5M
| $3.1M | 0.12% |
+3,157,895
| New | +$3.1M |
|
86
Scully Royalty
SRL
$77.5M
| $2.98M | 0.12% |
368,182
-414
| -0.1% | -$3.36K |
|
87
Senti Biosciences
SNTI
$36.1M
| $2.98M | 0.12% |
+888,000
| New | +$2.98M |
|
|
SLN
88
Silence Therapeutics
SLN
$227M
| $2.94M | 0.12% |
1,042,427
-7,249
| -0.7% | -$20.4K |
|
89
Structure Therapeutics
GPCR
$1.2B
| $2.92M | 0.12% |
168,553
-52,447
| -24% | -$908K |
|
|
GRCE
90
Grace Therapeutics, Inc. Common Stock
GRCE
$45.1M
| $2.69M | 0.11% |
+1,178,203
| New | +$2.69M |
|
91
Surrozen
SRZN
$101M
| $2.68M | 0.11% |
229,527
+33,504
| +17% | +$391K |
|
92
Reading International Class A
RDI
$35M
| $2.67M | 0.11% |
1,921,088
-942,958
| -33% | -$1.31M |
|
93
scPharmaceuticals
SCPH
$301M
| $2.62M | 0.1% |
995,438
-4,562
| -0.5% | -$12K |
|
94
Caesars Entertainment
CZR
$5.33B
| $2.47M | 0.1% |
98,879
-1,121
| -1% | -$28K |
|
95
Achieve Life Sciences
ACHV
$161M
| $2.4M | 0.1% |
898,885
+244,885
| +37% | +$654K |
|
96
Owens & Minor
OMI
$423M
| $1.81M | 0.07% |
+200,000
| New | +$1.81M |
|
97
Altisource Portfolio Solutions
ASPS
$125M
| $1.69M | 0.07% |
309,664
+43,628
| +16% | +$238K |
|
98
enVVeno Medical
NVNO
$15.1M
| $1.56M | 0.06% |
594,661
-2,256
| -0.4% | -$5.93K |
|
99
Edesa Biotech
EDSA
$17.2M
| $1.53M | 0.06% |
+625,000
| New | +$1.53M |
|
100
Kodiak Sciences
KOD
$524M
| $1.49M | 0.06% |
530,713
+264,100
| +99% | +$741K |
|